Glatiramer Acetate Follow-up in Participants From the Original Study for Safety and Effectiveness

Study Title
Glatiramer Acetate (Copaxoneֲ®) Study to Follow Participants From the First Original Study for Safety and Effectiveness
Teva Identifier
GA-9004 | 01-9004
ClinicalTrials.gov Identifier
NCT00203021
Study Status
Completed
Trial Condition(s)
Relapsing-Remitting Multiple Sclerosis
Interventions
Drug: Glatiramer acetate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years and older
Trial Duration
March 26, 1994 - February 28, 2018
Phase
Phase 4

Study Type

Interventional